GROUP ONE TRADING, L.P. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is P73398952. A total of 3 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$950
-65.9%
5,000
-39.0%
0.00%
Q1 2023$2,788
+14.5%
8,2000.0%0.00%
Q4 2022$2,435
-39.1%
8,200
-19.6%
0.00%
Q3 2022$4,0000.0%10,2000.0%0.00%
Q2 2022$4,000
-55.6%
10,200
+39.7%
0.00%
Q1 2022$9,0000.0%7,3000.0%0.00%
Q4 2021$9,000
-65.4%
7,300
-42.5%
0.00%
Q3 2021$26,000
+225.0%
12,700
+154.0%
0.00%
Q2 2021$8,000
+100.0%
5,000
+233.3%
0.00%
Q4 2020$4,000
-33.3%
1,500
-40.0%
0.00%
Q3 2020$6,000
+200.0%
2,500
+400.0%
0.00%
Q2 2020$2,000
-66.7%
500
-80.0%
0.00%
Q1 2020$6,0000.0%2,5000.0%0.00%
Q4 2019$6,000
-92.2%
2,500
-95.7%
0.00%
-100.0%
Q4 2018$77,000
-52.8%
58,400
-12.0%
0.00%0.0%
Q3 2018$163,000
-30.3%
66,400
-4.6%
0.00%
-50.0%
Q2 2018$234,000
-49.5%
69,600
-36.4%
0.00%
-60.0%
Q1 2018$463,000
+120.5%
109,500
+71.9%
0.01%
+400.0%
Q4 2017$210,000
-76.2%
63,700
-72.5%
0.00%
-87.5%
Q3 2017$884,000
-19.9%
231,300
-7.8%
0.01%
-27.3%
Q2 2017$1,104,000
-15.1%
250,900
-30.0%
0.01%
-26.7%
Q1 2017$1,301,000
+262.4%
358,400
+166.7%
0.02%
+400.0%
Q4 2016$359,000
+7.2%
134,400
+30.7%
0.00%
-25.0%
Q3 2016$335,000
+365.3%
102,800
+367.3%
0.00%
+300.0%
Q4 2015$72,00022,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 10,200$4,0000.00%
SIMPLEX TRADING, LLC 100$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders